Wockhardt is planning a proposal to demerge its research and development division. The board of the company will meet on January 18 to consider an in-principle approval to demerge its new chemical entities (NCE) and R&D operations, subject to the approval of shareholders and other regulatory authorities.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment